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Blending synthetic biology and synthetic chemistry represents a
powerful approach to diversity complex molecules. To further
enable this, compatible synthetic tools are needed. We report the
first Buchwald Hartwig amination reactions with unprotected halo-
tryptophans under aqueous conditions and demonstrate this meth-
odology is applicable also to the modification of unprotected
tripeptides and the natural product barettin.
Tryptophan is an essential amino acid, abundant within
peptides and proteins, and central to their fluorescence, folding
and structure;1 it is also an important component in many
bioactive natural products including non-ribosomal peptides
e.g., vancomycin, and a precursor to indole alkaloids e.g.,
vinblastine and vincristine.2 Modulation of tryptophan aﬀords
the potential to tune fluorescence, conformation and activity of
these (bio)molecules.3 Although there has been significant
research exploring the cross-coupling chemistry of nucleosides
and the aromatic amino acid phenylalanine, both in their free
state or as components of larger systems, the cross-coupling of
halotryptophan has seemingly received little attention. Metho-
dology now exists for the modification of halotryptophans, by
Sonogashira4 and Suzuki-Miyaura5,6 but, to the best of our
knowledge, the utilisation of Buchwald Hartwig amination (BHA)
of halotryptophans and their derivatives remains unexplored.
Whilst BHA conditions have been applied to a wide range of
aromatic species including indoles and 6-bromoquinolone
(Scheme 1A and B),7,8 to the best of our knowledge there is
no literature precedent for its use in unprotected biomolecule
functionalisation. Herein we report the application of aqueous
BHA coupling to 5-bromoindole (Scheme 1C) and unprotected
halotryptophans with a range of substituted aniline coupling
partners (Scheme 1D). We then present the BHA derivatisation
of tripeptides and the natural product barettin (Scheme 1E and F).
We set out to explore the feasibility of developing aqueous
conditions for BHA coupling of halotryptophans, which may be
readily accessed through a simple one-step biotransformation
of indoles using tryptophan synthase9 or through a 4–5 step
chemical synthesis.10 One challenge presented by free amino
acids in palladium coupling reactions is the amino acid’s ability to
chelate and deactivate the palladium catalyst.11 To reduce the like-
lihood of catalyst deactivation, we selected a precatalyst, L–Pd–G1 (2)
(Fig. 1) with the tBu-XPhos ligand, as shown by Buchwald and
co-workers.12 Initially, we examined the coupling of unprotected
5-bromoindole 3 and aniline 4.7 Investigating the impact of varying
aqueous solvent mixture, catalyst loading, aniline eq. and base
screening led us to conditions of 2 eq. of aniline, 2 mol%
[Pd(tBu-XPhos)G1] catalyst, 1.2 eq. K2CO3, THF :water (1 : 1) at
65 1C for 16 h (Scheme 2) giving an 85% yield of 5.
Translating these conditions directly to the more challenging
cross-coupling of 5-bromotryptophan, we saw a substantial drop
in yield. This prompted a further round of optimisation and a
move to microwave heating resulting in 56% isolated yield of the
cross-coupled product 7 (Scheme 2).
Next, we decided to take a closer look at the influence of
reaction time under the microwave conditions exploring the
impact of heating by microwave from 1 minute to 1.5 h (Table 1).
We found that shorter reaction times gave improved yields,
optimum at 8min (75% yield) (Table 1). It is suspected that longer
reaction times cause degradation of the product resulting in lower
yields, no clear by-products could be identified. Having estab-
lished utilisable conditions for the BHA of 5-bromotryptophan, we
investigated the reaction with tryptophans substituted with
bromo and chloro in varying positions (Table 2). The reaction
proceeded well for 5, 6 and 7-bromotryptophans resulting in
yields of 75, 51 and 68% respectively. Similarly, the 5, 6 and
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7-chlorotryptophans also worked well (67, 60 and 31% yields
respectively).
Having assessed reactivity of the various halotryptophans
with aniline, we next sought to examine the eﬀects of steric
and electronic properties of the aniline coupling partner. We
selected six anilines, 10 to 15, (Scheme 3 and Table 3) and
reacted these with 5- and 7-bromotryptophan; the two most
reactive regioisomers according to our positional scoping.
These results show that cross-coupling proceeded even in
the presence of moderate steric hindrance: 2-methylaniline (11)
reacted with 5- and 7-bromotryptophans nearly as eﬃciently as
unsubstituted aniline, with yields of 63% and 62% respectively.
However, it is striking that two methyl groups in close proximity
to the aryl amine, as in 2,6-dimethylaniline (12), led to complete
suppression of the reaction and recovery of starting materials.
Interestingly, N-methylaniline (13) is partially tolerated yielding
4% product for the 7-bromotryptophan, but no product could
be obtained for the 5-bromotryptophan.
Scheme 1 Buchwald Hartwig related work: examples of relevant prior
work are outlined along with work within this study. (A) Example literature
conditions for BHA on a bromoindole from Buchwald.7 (B) Buchwald
Hartwig coupling for a 6-bromoquinolone nucleoside, Wicke et al.8 (C)
Reported BHA modification for 5-bromoindole. (D) Reported BHA mod-
ifications for a range of halotryptophans. (E) Reported BHA modification of
a bromotryptophan containing tripeptide. (F) Reported BHA modification
the natural product barettin.
Fig. 1 Buchwald ligand tBu-XPhos 1 and precatalyst L–Pd–G1 2.
Scheme 2 Buchwald Hartwig Amination reaction of 5-bromoindole (3)
and 5-bromotryptophan (6) with aniline (4).
Table 1 Assessment of microwave reaction time on yield
Time of reaction (min) Yield (%)
1 43a
5 53a
8 75a
15 71a
30 71a
60 56b
90 35b
Conditions: 5-bromotryptophan (1 eq.), [Pd(tBu-XPhos)G1] (5 mol%),
KOH (4.0 eq.), aniline (2.0 eq.), H2O/1,4-dioxane (1 : 1, 0.6 mL), micro-
wave heating, sealed tube, under argon, 100 1C. a Isolated yield of the
product after reverse phase purification. b Yield assessed by 1H-NMR
using 1,3,5-tri-tert-butylbenzene as an internal standard.
Table 2 Reaction of a series of halotryptophans with aniline
Entry Tryptophan Product Isolated yield/%
1 5-Br 7 75
2 6-Br 8 51
3 7-Br 9 68
4 5-Cl 7 67
5 6-Cl 8 60
6 7-Cl 9 31
Conditions: halotryptophan (1 eq.), [Pd(tBu-XPhos)G1] (5 mol%), KOH
(4.0 eq.), aniline (2.0 eq.), H2O/1,4-dioxane (1 : 1, 0.6 mL), microwave
heating, sealed tube, under argon, 8 min, 100 1C.
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Diﬀerently substituted anilines, bearing electron-withdrawing
or electron-donating groups, were subsequently tested to assess
the impact of the electronic properties of the nucleophile in our
reaction. With the weakly electron donating para-methyl substi-
tuent, we saw a slight drop in yield from 75% and 68% to 59%
and 53% respectively for the 5- and 7-bromotryptophans. It was
predicted13 that the strong electron withdrawing nature of the CF3
substituent would reduce the reactivity of the aniline towards
amination and this was borne out in the very low isolated yields
(7 and 15%, Table 3, entries 9 and 10). Also, as anticipated, the
electron rich trimethoxyaniline reacted well (67 and 59% yields
Table 3, entries 11 and 12), but did not surpass the yields observed
for the unsubstituted anilines reactions. The slightly lower than
expected yield for 15 may be due to improved organic solubility
of the products resulting in a slight loss of product during the
work up.
We next tested the reaction withmore complex halotryptophan
containing substrates. Tripeptides 16, 17 and 18 were synthesised
(see ESI†) and were subjected to our BHA conditions (Scheme 4)
using p-toluidine (10) as the coupling partner and increasing the
reaction times to allow for potentially slower reaction with the
more complex molecules. Tripeptide 17 reacted well and a 99%
isolated yield was achieved. The products of tripeptides 16 and 18
suﬀered losses during purification. In particular peptide 21 had
poor stability in solution and required careful handling to isolate
high purity material. These examples demonstrate the successful
BHA coupling of halotryptophan present at either terminal or
middle locations in an unprotected peptide sequence possessing
polar/non-polar side chains.
Encouraged by these results, we next chose derivatisation of
barettin a marine natural product reputed to have antioxidant and
anti-inflammatory properties and containing a 6-bromotryptophan
group. Using our standard conditions (Scheme 5) we observed full
consumption of starting material. LCMS showed a distinct peak at
4.3 min with an [M + H]+ of 446 corresponding to the desired
product. Despite the small scale and purification diﬃculties, we
were able to isolate 1 mg of the product 23 following HPLC
purification, (purity 495%, 16% yield).
We have for the first time demonstrated the use of Buchwald
Hartwig Amination to diversify free unprotected 5, 6 and
7-bromo- and chlorotryptophans, and shown the reaction is
also eﬀective on short 7-bromotryptophan containing peptides
including potentially reactive groups such as glutamic acid and
lysine. The reaction products can be isolated by reverse-phase
chromatography or HPLC. As seen in our previous work,6b
following the cross-coupling reaction, the tripeptides were
single peaks by HPLC(LCMS) (see ESI†) indicating presence of
single diastereomers and therefore no observable epimerisa-
tion occurred during the cross-coupling reactions. Our new
conditions were also successfully applied to the more complex
Scheme 3 Investigating the reaction of 5-bromo and 7-bromotryptophans
with a selection of anilines.
Table 3 Investigating the reactivity of 5-bromo and 7-bromotryptophans
with a selection of anilines
Entry Tryptophan Product Isolated yield/%
1 5-Br 10a 59
2 7-Br 10b 53
3 5-Br 11a 63
4 7-Br 11b 62
5 5-Br 12a No reaction
6 7-Br 12b No reaction
7 5-Br 13a No reaction
8 7-Br 13b 4
9 5-Br 14a 7
10 7-Br 14b 15
11 5-Br 15a 67
12 7-Br 15b 59
Conditions: bromotryptophan (1 eq.), [Pd(tBu-XPhos)G1] (5 mol%),
KOH (4.0 eq.), anilines (2.0 eq.), H2O/1,4-dioxane (1 : 1, 0.6 mL), micro-
wave heating, sealed tube, under argon, 8 min, 100 1C.
Scheme 4 Investigating the reaction of 7-bromotryptophan containing
tripeptides with p-toluidine (10).
Scheme 5 BHA reaction of barettin with p-toluidine (10).
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natural product barettin. This provides an expansion of the
reactions that can be carried out with easily accessed9 halotrypto-
phans that can be incorporated into more complex peptides and
natural products. The incorporation of the halotryptophans and
wide range of amine coupling partners could be envisioned to
produce a wide variety of natural product analogues for use in
structure–activity relationship analyses.
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